Gene: ZDHHC1
Official Full Name: zDHHC palmitoyltransferase 1provided by HGNC
Gene Summary: Enables protein-cysteine S-palmitoyltransferase activity. Involved in antiviral innate immune response; protein palmitoylation; and regulation of defense response. Located in Golgi apparatus and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27038 | ZDHHC1 Knockout cell line (HCT 116) | Human | ZDHHC1 | 1:2~1:4 | Negative | Online Inquiry |
KO27039 | ZDHHC1 Knockout cell line (HEK293) | Human | ZDHHC1 | 1:3~1:6 | Negative | Online Inquiry |
KO27040 | ZDHHC1 Knockout cell line (A549) | Human | ZDHHC1 | 1:3~1:4 | Negative | Online Inquiry |
ZDHHC1 Gene Knockout Cell Lines are specialized cellular models developed to study the biological functions of the ZDHHC1 gene, which encodes a protein known to play a crucial role in palmitoylation, a post-translational modification vital for various cellular processes. These cell lines are engineered to have the ZDHHC1 gene knocked out, providing a powerful tool for exploring the consequences of its absence on cellular behavior, signaling pathways, and disease mechanisms.
The key function of these knockout cell lines is to facilitate the investigation of the biological effects of ZDHHC1 loss. This is achieved through various methodologies, such as gene expression analysis, proteomic profiling, and functional assays, which can elucidate the molecular pathways influenced by ZDHHC1 activity. By utilizing CRISPR-Cas9 technology or other genome editing techniques, the ZDHHC1 Gene Knockout Cell Lines allow researchers to analyze how the absence of this gene affects cellular functions such as growth, differentiation, and response to stress, thereby providing insights into potential therapeutic targets.
In research and clinical settings, these cell lines have substantial scientific importance. They can be utilized to model diseases linked to aberrant palmitoylation, such as neurodegenerative disorders or cancer, thus accelerating the discovery of novel treatment strategies. Moreover, the ZDHHC1 knockout models can be pivotal in drug testing and biomarker discovery, enhancing the precision of therapeutic interventions.
Compared to traditional cell lines that express ZDHHC1, these knockout models present unique advantages by providing a clear contrast, enabling researchers to isolate and analyze specific effects due to gene loss without confounding variables from endogenous expression levels. Additionally, they offer improved reproducibility and reliability in experimental results, which are critical for advancing scientific knowledge.
For researchers and clinicians, the ZDHHC1 Gene Knockout Cell Lines represent a valuable resource for fundamental biological research and translational applications. Understanding the role of ZDHHC1 could lead to breakthroughs in therapeutic strategies for diseases where palmitoylation is disrupted, ultimately contributing to improved patient outcomes.
Our company specializes in the development and provision of advanced genetic tools and cell models, underscoring our commitment to enhancing research capabilities with innovative products designed for the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.